IDO1 and cancer: Indoleamine‐2,3‐dioxygenase 1 (IDO) is a key factor in defining cancer immunogenicity [22] and is a cytosolic enzyme catalyzing the first and rate‐limiting step of tryptophan (Trp) catabolism.